Michael Carrier
Stock Analyst at B of A Securities
(3.95)
# 656
Out of 4,734 analysts
224
Total ratings
71.79%
Success rate
22.59%
Average return
Main Sectors:
Stocks Rated by Michael Carrier
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MS Morgan Stanley | Maintains: Buy | $146 → $153 | $137.30 | +11.43% | 13 | Jan 17, 2025 | |
| PHAR Pharming Group | Maintains: Outperform | $31 → $30 | $9.55 | +214.14% | 2 | Oct 28, 2024 | |
| NTRS Northern Trust | Maintains: Buy | $103 → $115 | $107.75 | +6.73% | 12 | Oct 24, 2024 | |
| TW Tradeweb Markets | Maintains: Buy | $134 → $139 | $127.91 | +8.67% | 6 | Oct 3, 2024 | |
| CBOE Cboe Global Markets | Maintains: Buy | $200 → $204 | $197.17 | +3.46% | 17 | Apr 19, 2024 | |
| GS The Goldman Sachs Group | Downgrades: Neutral | $490 → $475 | $634.74 | -25.17% | 6 | Jan 6, 2022 | |
| AB AllianceBernstein Holding L.P. | Downgrades: Neutral | $42 | $39.79 | +5.55% | 12 | Apr 9, 2021 | |
| VCTR Victory Capital Holdings | Upgrades: Buy | $24 → $32 | $67.58 | -52.65% | 4 | Apr 9, 2021 | |
| BK BNY Mellon | Upgrades: Buy | $43 → $50 | $84.93 | -41.13% | 10 | Mar 24, 2021 | |
| CME CME Group | Upgrades: Buy | $200 → $220 | $232.25 | -5.27% | 10 | Mar 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $19 → $14 | $9.91 | +41.27% | 1 | Mar 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $68 | $80.93 | -15.98% | 9 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $154 | $113.80 | +35.33% | 9 | Nov 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $76 | $89.20 | -14.80% | 9 | Nov 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $26 | $19.82 | +31.18% | 9 | Oct 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $71 → $70 | $99.00 | -29.29% | 10 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $633 → $675 | $1,012.09 | -33.31% | 6 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $140 → $154 | $210.69 | -26.91% | 7 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $17.50 | -37.14% | 6 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $70 → $71 | $188.73 | -62.38% | 5 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $40 | $160.71 | -75.11% | 6 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $25 → $27 | $56.41 | -52.14% | 10 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $62 → $58 | $181.52 | -68.05% | 5 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $44 | $194.72 | -77.40% | 7 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $54 → $53 | $169.24 | -68.68% | 3 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $47 | $79.87 | -41.57% | 7 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $19.52 | - | 4 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $17 → $13 | $43.55 | -70.15% | 2 | Mar 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $22 → $15 | $38.34 | -60.88% | 1 | Mar 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $23 → $18 | $43.90 | -59.00% | 3 | Mar 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $99 → $81 | $151.72 | -46.61% | 4 | Mar 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $57 → $39 | $1.05 | +3,614.29% | 9 | Oct 2, 2019 |
Morgan Stanley
Jan 17, 2025
Maintains: Buy
Price Target: $146 → $153
Current: $137.30
Upside: +11.43%
Pharming Group
Oct 28, 2024
Maintains: Outperform
Price Target: $31 → $30
Current: $9.55
Upside: +214.14%
Northern Trust
Oct 24, 2024
Maintains: Buy
Price Target: $103 → $115
Current: $107.75
Upside: +6.73%
Tradeweb Markets
Oct 3, 2024
Maintains: Buy
Price Target: $134 → $139
Current: $127.91
Upside: +8.67%
Cboe Global Markets
Apr 19, 2024
Maintains: Buy
Price Target: $200 → $204
Current: $197.17
Upside: +3.46%
The Goldman Sachs Group
Jan 6, 2022
Downgrades: Neutral
Price Target: $490 → $475
Current: $634.74
Upside: -25.17%
AllianceBernstein Holding L.P.
Apr 9, 2021
Downgrades: Neutral
Price Target: $42
Current: $39.79
Upside: +5.55%
Victory Capital Holdings
Apr 9, 2021
Upgrades: Buy
Price Target: $24 → $32
Current: $67.58
Upside: -52.65%
BNY Mellon
Mar 24, 2021
Upgrades: Buy
Price Target: $43 → $50
Current: $84.93
Upside: -41.13%
CME Group
Mar 24, 2021
Upgrades: Buy
Price Target: $200 → $220
Current: $232.25
Upside: -5.27%
Mar 24, 2021
Downgrades: Underperform
Price Target: $19 → $14
Current: $9.91
Upside: +41.27%
Jan 12, 2021
Upgrades: Buy
Price Target: $68
Current: $80.93
Upside: -15.98%
Nov 19, 2020
Downgrades: Neutral
Price Target: $154
Current: $113.80
Upside: +35.33%
Nov 19, 2020
Upgrades: Buy
Price Target: $76
Current: $89.20
Upside: -14.80%
Oct 9, 2020
Upgrades: Buy
Price Target: $26
Current: $19.82
Upside: +31.18%
Jul 20, 2020
Maintains: Buy
Price Target: $71 → $70
Current: $99.00
Upside: -29.29%
Jul 20, 2020
Maintains: Buy
Price Target: $633 → $675
Current: $1,012.09
Upside: -33.31%
Jul 10, 2020
Maintains: Buy
Price Target: $140 → $154
Current: $210.69
Upside: -26.91%
Jul 10, 2020
Maintains: Neutral
Price Target: $12 → $11
Current: $17.50
Upside: -37.14%
Jul 10, 2020
Maintains: Underperform
Price Target: $70 → $71
Current: $188.73
Upside: -62.38%
Jul 10, 2020
Maintains: Buy
Price Target: $36 → $40
Current: $160.71
Upside: -75.11%
Jul 10, 2020
Maintains: Underperform
Price Target: $25 → $27
Current: $56.41
Upside: -52.14%
Jul 10, 2020
Maintains: Neutral
Price Target: $62 → $58
Current: $181.52
Upside: -68.05%
Jul 10, 2020
Maintains: Buy
Price Target: $43 → $44
Current: $194.72
Upside: -77.40%
Jul 10, 2020
Maintains: Neutral
Price Target: $54 → $53
Current: $169.24
Upside: -68.68%
Jul 10, 2020
Maintains: Buy
Price Target: $43 → $47
Current: $79.87
Upside: -41.57%
Mar 24, 2020
Downgrades: Perform
Price Target: n/a
Current: $19.52
Upside: -
Mar 23, 2020
Maintains: Underperform
Price Target: $17 → $13
Current: $43.55
Upside: -70.15%
Mar 23, 2020
Maintains: Underperform
Price Target: $22 → $15
Current: $38.34
Upside: -60.88%
Mar 23, 2020
Maintains: Underperform
Price Target: $23 → $18
Current: $43.90
Upside: -59.00%
Mar 23, 2020
Maintains: Buy
Price Target: $99 → $81
Current: $151.72
Upside: -46.61%
Oct 2, 2019
Downgrades: Underperform
Price Target: $57 → $39
Current: $1.05
Upside: +3,614.29%